-
The onset of the PEACE consortium for improving prostate cancer phase 3 trials, according to its founder Karim Fizazi
In the early 2010s, many European centres joined forces to form the Prostate Cancer Consortium in Europe (PEACE) to carry out phase 3 trials in prostate cancer field. After about 10 years, 7 projects, PEACE-1 is now the first trial of the PEACE programme to be completed that has put into the market the triplet therapy for patients with metastatic prostate cancer.
Author:Camilla Fiz
Date of publication:Read more02 January 2025
-
Yes we scan: how MRI was trained on the prostate for detection and diagnosis
Finding out if there is cancer in the prostate and if it is clinically significant has been a major problem because it is hard to image the organ. But magnetic resonance imaging (MRI) has that capability – and the development of MRI technology and its applications including the prostate are European stories. However, proponents have had to battle resistance to its use by some urologists.
Author:Simon Crompton
Date of publication:Read more05 October 2022
-
PSA testing for prostate cancer: navigating controversy
Prostate specific antigen (PSA) is the biomarker used for early detection of prostate cancer. It has been one of the most controversy topics in all of medicine, with Europe playing a key role in providing and refining the evidence base for its use.
Author:Simon Crompton
Date of publication:Read more07 September 2022
Coming soon
- Nerve-sparing radical prostatectomy
- Hormono-chemotherapy of advanced prostate cance
- History of radiotherapy of prostate cancer